XIIDRA
Google image searchProduct monograph
Active ingredient
lifitegrast, 5 %/W/V
DIN: 02471027
Dosage form(s): SOLUTION
Route(s) of administration: OPHTHALMIC
Description: SINGLE-USE CONTAINERS
Schedule: Prescription
Company: BAUSCH & LOMB INC
Date: 20-AUG-2024
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01X — OTHER OPHTHALMOLOGICALS (ATC, ATC/DDD)
- S01XA — Other ophthalmologicals (ATC, ATC/DDD)
- S01XA25 — LIFITEGRAST (ATC/DDD)
